Abstract: This study considers the influence of exposure to simulated gastrointestinal conditions (saliva, gut, intestine and acidic conditions of the gut) on IgG binding of unmodified allergens and three types of LMW allergoids of Artemisia vulgaris pollen extract obtained by means of potassium cyanate, succinic and maleic anhydride. It also concerns the optimization of a self-developed ELISA assay for comparison of the specific IgG binding of mugwort pollen extract and modified mugwort pollen derivatives. The ELISA was conducted with a mugwort pollen extract coupled to the plate, using the sera from 12 mugwort-pollen allergic patients. The exposure to saliva fluid for 2 min did not influence the IgG binding properties of allergens and allergoids. Exposure of mugwort pollen allergens and LMW allergoids to the acidic conditions of the gut did not dramatically change their IgG binding properties. By exposing mugwort pollen extract and LMW derivatives to the SGF conditions for 1 h, the percent of IgG binding epitopes was reduced to a half of its starting value in the extract and to about 30 % in all the allergoid samples. After prolonged exposure only the carbamyl derivative showed reduced IgG binding. Changes of the IgG binding potential of all four samples after exposure in SIF followed a similar pattern.
INTRODUCTION
Different forms of local immunotherapies of allergic diseases [1] [2] [3] [4] as well as chemical modification of allergens were mainly considered to be a safe way of administering allergenic extracts. In local forms of immunotherapy, some low-molecular weight allergoids could also find application. Low-molecular weight (LMW) derivatives of allergens are modified forms of allergens of the same (native) size as the unmodified ones. Two prinicpal approaches were undertaken to obtain LMW allergoids: carbamylation [5] [6] [7] and acid anhydrides treatment. 8, 9 Such derivatives reduce the allergenicity while preserving the ability to induce blocking of IgG antibodies, whose increased level during allergen-specific immunotherapy correlates well with clinical improvements. 10 Thus, the retention of IgG-binding epitopes on the modified allergens is of significance in the protection against harmful effects of IgE-mediated allergic reactions that could appear during local allergen delivery throughout the gastrointestinal tract of an allergic person, especially because it has been shown that there is a fraction of IgG antibodies in mucosal secretions that contributes to the immunity of mucosa, besides IgA antibodies. 10 A study of the digestion stability of birch, timothy, ragweed and mugwort pollen extracts showed a remarkable difference among the investigated allergenic extracts. Mugwort pollen extract was shown to be the source of the most resistant allergens. Adouble-band fraction of 28 -35 kD was isolated from mugwort pollen which was a pepsin-resistant allergen. 11 Moreover, its prolonged and limited digestion in the gut could raise the question of higher incidence rates of side-effects during local immunotherapy trials. Regarding this, a better knowledge of how the mugwort pollen derivatives behave in simulated conditions of the gut, might be important in optimizing the dosage of the extracts used in local forms of immunotherapy conducted with allergenic extracts rich in these pepsin-resistant allergens.
This study considers the dependence of exposure to simulated in vivo gastrointestinal conditions on the IgG binding of three types of LMW allergoids of Artemisia vulgaris pollen extract. Although all three reactants act on the e-amino group of Lys, the bonds formed in such a way differ in chemical stability as well as stereochemistry 12 and yield quite different modification products. A self-developed ELISA assay was also optimized to compare the specific IgG binding of untreated mugwort pollen extract and modified mugwort pollen derivatives.
RESULTS AND DISCUSSION
Human sera: The characteristics of the group of patients included in the study (8 men and 4 women; aged 28 -55) are shown in Table I . For the pool used in the ELISA testing, the values for the total and specific IgE were determined to be: 586 kUA/l and 12.8 kUA/l, respectively.
IgG binding: The values obtained for the IgG binding of untreated samples were in the order: mugwort pollen sample, carbamyl derivative, maleyl derivative and succinyl derivative. The values were in agreement with published observations that the succinyl derivative binds IgG from the pool of the sera of allergic patients to a lesser extent than the other samples tested. According to the majority of the assays included in a previous study, the succinyl modification gave derivatives with the most changed IgE and IgG binding properties when compared to the native sample.
The influence of saliva exposure. The exposure to saliva fluid for 2 min did not influence the IgG binding properties of allergens and allergoids, as demonstrated by measuring the residual IgG binding in the samples (Figs. 1-4) . In sublingual forms of IT, 2 min absorption through mucosa did not change the properties of the derivatives introduced. With respect to the side-effects of SLIT on the mouth (itching and oedema), 1, 13 the stability of the derivatives tested is very important. The influence of exposure to the acidic conditions of gastric fluid. According to the percent of residual IgG binding, after 4 h of gastric exposure, the acyl derivatives start to hydrolyze (Figs. 2 and 3) , liberating IgG epitopes blocked by the modification reaction. The carbamyl derivative did not change its IgG binding potential in the very acidic conditions of the gut environment (Fig. 4) .
The influence of exposure to gastric fluid. On exposing the mugwort pollen extract (Fig. 1) and the low-molecular derivatives to simulated gastric fluid (SGF) conditions for 1 h (Figs. 2-4) , the percent of IgG binding epitopes was reduced to half of its starting value. In all the samples, the residual protein remained fully resistant to digestion and contributed to IgG binding. Its IgG binding potential was still below the value of the native extract, however, a significant proportion of almost 75 % of the IgG binding epitopes remained in the modified derivatives when compared to the native sample. The influence of exposure to intestine fluid. Although exposure to SIF conditions significantly reduces the allergenic potential of the derivatives, 11 presumably by digestion of the pepsin resistant mugwort pollen allergen, the IgG binding potential after 2 h exposure was similar to the SGF treated samples after 1 h (Figs. 1-4) . A portion of the residual peptide fragments contributed to the extent of inhibition.
Pollen allergens are generally believed to be labile under the conditions of the gut environment. Some earlier reports suggest rapid degradation of grass and tree pollen proteins in the gut and duodenal fluids. [14] [15] [16] [17] Regarding the observation that not all of the pollen allergens degrade rapidly 10 and possible immunotherapy trials of acid anhydride derivatives, it was important to investi- Fig.4 . ELISA inhibiton of IgG binding for carbamyl derivatives of mugwort pollen proteins before and after simulated gastrointestinal exposure. Control-non treated carbamyl derivatives of mugwort pollen proteins; saliva-saliva treated sample; 1 h-sample after 1 h treatment with the acidic conditions of the gut; 4 h-sample after 4 h treatment with the acidic conditions of the gut; sgf*-simulated gastric juice treated sample; sif*-simulated intestinge juice treated sample; 1 h, 2 h and 4 h-duration of the treatment. gate the IgG binding properties of these derivatives in the simulated environments of patients' saliva, gut and intestine, in order to achieve a fine tuning of the local immunotherapy dosage of these derivatives. This study showed that the retention of IgG binding epitopes in the modified derivatives is greater than that of the unmodified sample. One of the reasons might be a reduced hydrolysis of the derivatives in the acidic conditions of the gut (as seen after 4 h exposure), but also the modifications might protect the derivatives against proteolitic cleavage. Additionally, the effect of deacylation on the extent of IgG binding is of greater magnitude when compared to the IgE binding of the same samples. 11 As most of the proteins both in the native and modified samples are degraded under SIF conditions, the blocking effect is more pronounced regarding the simulated intestinal conditions, presumably because of the protecting effect on the e-amino group of Lys, the target of trypsin, which is the main component of pancreatin juice.
EXPERIMENTAL
Allergen and allergoids preparations. Pollen extracts as well as the modified derivatives were prepared as described previously. 8, 9, 18 The carbamyl derivative was prepared according to Mistrello et al. 5 The protein concentrations were determined by the Bradford method. 19 The simulated saliva experiments. The simulated saliva fluid (SSF) consisted of 2.38 g Na 2 HPO 4 , 0.19 g KH 2 PO 4 , 8 g NaCl/l adjusted with phosphoric acid to pH 6.75. 150 mg of allergoids and unmodified samples were exposed to 150 ml SSF for 2 min at 37 ºC. After exposure the samples were immediately transferred to an ice-bath and kept frozen until analyzed.
The simulated gastric juice experiments. The simulated gastric fluid (SGF) consisted of 0.1 M HCl, 2 g/L NaCl and 3.2 g/L pepsin (Sigma). The same fluid was prepared without addition of pepsin. The allergens and alelrgoids were exposed to SGF both with and without pepsin for 1 and 4 hours in accordance with conditions described earlier. 20 The reaction was stopped by the addition of 1 M sodium bicarbonate to the pH value of 7.2.
The simulated intestine juice experiments. The simulated intestine fluid consisted of phosphate buffer pH 7.4, and 10 g/l of pancreatin (Sigma) in accordance with US Pharmacopoeia. The samples were exposed to SIF for 2 and 4 hours. The reaction was stopped by freezing the sample.
Human sera. The sera from 12 patients with a documented clinical history of mugwort pollen allergy and with a recorded course of specific immunotherapy to mugwort pollen were used. The patients had documented clinical histories of allergic rhinitis, allergic asthma, allergic rhinoconjunctivitis and allergic conjunctivitis. Sera from five non-atopic persons were pooled and used as a control. The values of the total and mugwort pollen specific IgE in the pooled sera were determined by the UniCap (Pharmacia, Uppsala, Sweden) system.
ELISA and ELISA inhibition. ELISAs were performed as described previously. 21 Briefly, microtiter plates (Nunc, Maxi sorp) were coated with 50 ml of mugwort extract (7 mg/ml) overnight at room temperature and washed with TBS/0.1 % Tween 20. After blocking with 100 ml of 1 % BSA in TBS/0.1 % Tween 20, 50 ml of six-fold diluted pooled human sera, incubated with 50 ml of diluted allergen or allergoids (at the concentration of 4 mg/ml) in tubes for 30 min at 4 ºC, were added to the plates. The saliva, SGF and SIF exposed samples were diluted to the same volume as were untreated proteins. As a positive control, the human serum pool was incubated with saliva, SGF or SIF solutions diluted to the same volume as the samples and ovalbumin of the same concentrations as the samples or with TBS alone. For inhibition, diluted solutions of all samples were prepared with a diluting buffer consisting of TBS-0.5 % BSA. Human sera from persons with negative skin tests to mugwort pollen extract was used as a negative control. As a second antibody, anti-human IgG antibody labelled alkaline phosphatase (Sigma) was used. The absorbance values were measured at 405 nm after adjusting the background with a negative control. The percent of inhibiton was calculated in accordance with the formula previously described 21 and from the appropriate positive control. Predmet ovog rada je ispitivawe promena IgG vezivawa nemodifikovanih alergena polena A. vulgaris i tri tipa alergoida malih molekulskih masa dobijenih tretmanom sa kalijum-cijanatom, i anhidridima }ilibarne i meleinske posle izlagawa uslovima gastrointestinalnog trakta (saliva,`eludac, tanko crevo i kisela sredina`eluda~nog soka) i optimizacija doma}eg ELISA testa za odre|ivawe IgG vezivawa alergena i alergoida polena pelina. U ELISA testu je za plo~icu kuplovan ekstrakt polena pelina i kori{}eni su serumi 12 pacijenata alergi~nih na pelin. Izlagawe salivi u trajawu od 2 minuta ne uti~e na IgG vezuju}e osobine alergena i alergoida. Izlagawe kiseloj sredini`eluda~nog soka zna~ajno ne uti~e na IgG vezuju}e osobine alergena i alergoida polena pelina. Posle izlagawa simuliranom`eluda~nom soku alergena i derivata u trajawu od 1 sata, procenat IgG vezuju}ih epitopa u nemodifikovanom uzorku se smawuje na polovinu po~etne vrednosti i na oko 30 % kod sva tri derivata. Jedino se kod karbamil-derivata % IgG vezivawa dodatno smawuje sa produ`avawem izlagawa SGF-u. Promene u IgG vezuju}em potencijalu sva 4 uzorka posle izlagawa simuliranim uslovima tankog creva prate sli~an obrazac. (Primqeno 18. decembra 2003) 
